innovation for life science

Personalized solutions for life-science R&D.

We turn your most painful R&D bottlenecks into working solutions: a running proof of concept plus an implementation-ready plan, in four weeks at fixed scope.

See Personalized Solutions ↓
pharmamedtech
B2BBasel/FreiburgEst. 2022life-sciencePersonalized Solutions

personalized solutions

Two industries. One way of working.

We turn one bottleneck into a working PoC and an implementation-ready plan in four weeks, adapted to your industry and your phase.

Pharma

Research & DiscoveryDevelopmentClinical

From early discovery to clinical operations.

Explore

MedTech

DesignDevelopment & Approval

From product design to regulatory approval.

Explore

You are in good company

01 · the pattern

Most AI pilots in life science never leave the pilot phase.

Three patterns we see on the ground, drawn from our 5-Pitfalls framework for R&D transformations.

  1. 01

    Overestimated internal capacity

    Teams are asked to transform while running BAU. The transformation slips first.

  2. 02

    Structural focus without cultural shift

    Reorgs ship; new behaviours don’t. PoCs stall at adoption.

  3. 03

    Late resistance detection

    No psychological-safety mechanism surfaces friction early, so it lands as a Week-12 surprise.

02 · the product

"To accelerate your R&D, you are the strategist; we are your compass."

Personalized Solutions 4 weeks · fixed scope

From one R&D bottleneck to a working PoC in four weeks, delivered by senior practitioners.

Powered by our R&D in a Box method, four pillars in every engagement: software tools · automation · data integration · customisation.

  1. Week 1

    Understand

    1 day on-site · 8–10 stakeholders

    Deliverable →

    Goal-aligned engagement brief

  2. Week 2

    Analyze

    Internal + market/competitor scan

    Deliverable →

    Weighted list of bottlenecks, scored

  3. Week 3

    Plan

    Hybrid co-creation w/ your SMEs

    Deliverable →

    Costed project briefs, ROI model, prioritized roadmap

  4. Week 4

    PoC

    Hands-on, expanded stakeholder group

    Deliverable →

    Working automation / AI tool in your environment

FAQ

We don’t have a use case yet.
Week 1 surfaces it. You don’t bring the problem pre-scoped.
Data residency?
Work happens in Swiss/EU jurisdictions. See Privacy for exact tooling list.
Who signs the NDA?
Mutual NDA before Week 1. IP stays with you.
What if the PoC fails?
We scope for delivery. If Week 3 signals infeasibility, we redirect before PoC build.
Download the one-pager ↓

03 · the outcome

  1. 5×
    daily processing capacity
    Compound hub · Swiss biopharma
  2. 3×
    early-development candidates
    AI mRNA facility · German biotech
  3. ~35%
    efficiency improvement
    Digital Biorepository · Swiss pharma

04 · the proof

Work.

Digital Biorepository · Swiss pharma client

Background
Cross-site collaboration on bio-sample management: biosamples (cells, proteins, plasmids, antibodies) distributed across multiple locations with no clear structure. Tracing, accessing, and collecting the right samples was slow; scientific productivity was capped.
Solution
A global virtual + physical solution to handle, search, and retrieve biosamples. Secure cross-site sharing, AI-contextualised digital + physical storage, and an integrated request → register → store workflow.
Results
Remote and centralised access to bio samples. Faster data access. Lower experiment time and cost. ~35% efficiency improvement.
inite's role
inite concepted, designed, and managed the full DBR implementation across life-science, IT, and business domains. Delivered a standardised Bio-Sample Data Model aligned with FAIR data principles. Aligned multiple sites and functions on a single workflow.
Customer quote

“Inite positively influenced a change of mindset and supported us to approach the task with fresh thinking. Their approach allowed the team to imagine solutions in an unlimited way rather than being held back by challenges, constraints, and obstacles.”

Global Process Owner, Biosample Management · Global Pharma Company

Automated Compound Hub · Swiss biopharma client

Background
Growing global volume of compound orders for powder-solution production with varying priorities. The compound-management team was strained on productivity, sample tracking, and prioritisation.
Solution
Personalized Solutions workshop to optimise workflows, then a fully automated platform for powder weighing and liquid handling, designed for global rollout, with throughput, safety, and priority handling built in.
Results
Daily processing capacity up by more than 500%. Lab processes automated and optimised. Global standardisation of order processing across the department.
inite's role
inite provided a Scientific Business Analyst and Solution Architect. Owned system specifications and the functional-design phase. Architected the high-throughput solution. Negotiated with stakeholders to reconcile business and technical requirements.
Customer quote

“Inite has contributed significantly to the success of our projects with excellent and well-founded analyses. Their structure and committed way of working was greatly appreciated by the team. Due to their high level of expertise, requirements were defined very precisely to understand the operator and system needs.”

Compound Management Director · Global Pharma Company

AI mRNA Facility · German biotech client

Background
A research organisation expanded rapidly through multiple acquisitions, driven by funding and portfolio diversification. The brief: maximise the value of those acquisitions and integrate the teams without losing momentum on candidate selection.
Solution
Personalized Solutions to structure the integration. The flagship project: an mRNA facility for in-vivo screening to accelerate candidate selection. A self-learning platform connecting synthetic biology, IVT, and immunomodulation, surfacing correlations between sequence design and cellular expression.
Results
300% increase in early-development candidates vs. the year before. 40% of scientists’ time freed for creative work rather than repetitive tasks.
inite's role
inite owned full implementation: project lead, engineering, and implementation monitoring. Architected the high-throughput solution. Negotiated with stakeholders to find the best path to the goal.
Customer quote

“inite's strength was to create and implement systems and structures that helped us be more efficient and effective in the way we work. The ability not to force these structures but align with the stakeholders made them a trusted advisor for us.”

COO · Global Biotech Company

Digital Homecare Testing · Swiss diagnostic client

Background
A declining business: therapy innovations reduced the need for frequent diagnostic testing, and traditional point-of-care devices in hospitals and GP practices were losing relevance. The device itself had excellent analytical performance, but outdated Bluetooth connectivity, while patients and providers increasingly demanded flexible, remote care.
Solution
Shift from clinic-based diagnostics to a homecare testing model. A QR-code system carrying key patient and test information, plus a web-portal platform connecting patients directly with their treating physicians, compliant with national regulations and multilingual for global scalability.
Results
Business model transformed from clinical diagnostics to scalable, patient- and nurse-driven homecare testing. 600% global sales growth within 3 years while reducing the burden on hospitals and GP practices. Better patient outcomes through closer physician communication and higher treatment adherence.
inite's role
inite led the concept design and implementation of the digital solution. Built a secure QR-code generation system and a scalable patient–physician web platform with the client's R&D and IT teams. Ensured country-specific regulatory and data compliance, with a user-friendly interface for patients and professionals alike.
Customer quote

“inite's strength lies in designing and implementing effective systems and structures that significantly improve efficiency and ways of working. What sets them apart is the ability to align these changes with stakeholder needs rather than imposing them, which consistently builds trust.”

International Business Leader · Global Diagnostic Company

Early Cancer Detection Platform · German diagnostic client

Background
Clinical imaging is a highly competitive market where innovation is largely driven by hardware. Differentiating from other strong products inside the company's own portfolio became the strategic priority for future growth and market positioning.
Solution
A cloud-based, AI-driven early cancer detection platform integrating multiple diagnostic offerings, connecting diagnostic data sources for comprehensive, patient-centric insights. Two objectives in one move: clear differentiation from traditional clinical imaging, and an optimised patient journey with stronger market acceptance.
Results
Migration from on-premise to cloud: globally scalable, with savings of roughly €10M. Global cross-functional R&D teams established (IT, biology, medical, analytics). Multi-omics innovation and SaaS-based clinical products with revenue potential exceeding €50M.
inite's role
inite developed the concept to identify and leverage the portfolio's unique differentiators, led the design and implementation of the digital solution, and delivered a user-friendly interface for both patients and healthcare professionals.
Customer quote

“inite's strength lies in designing and implementing effective systems and structures that significantly improve efficiency and ways of working. The ability to align these changes with stakeholder needs rather than imposing them consistently builds trust.”

Global Head of Oncology R&D · Diagnostic Company

AI Traceability Graph · MedTech client

Background
A remote-patient-monitoring and at-home diagnostics company could not trace changes consistently across hardware, firmware, mobile app, cloud, and analytics. Which requirement a change addressed, which risk it mitigated, which tests provided the evidence: often unclear. Design reviews slowed; coverage gaps surfaced late.
Solution
Personalized Solutions to pinpoint the traceability breakpoints, then an AI Traceability Graph connecting user needs, requirements, design changes, risks, tests, defects, and evidence across the tools the teams already use, auto-suggesting links, flagging inconsistencies, and generating standardised traceability packs for design reviews.
Results
Design-review preparation time down 30–50% through automated traceability packs. Verification gaps caught earlier: less late rework, fewer change loops. End-to-end traceability from requirement to change to test evidence across hardware, firmware, app, cloud, and analytics.
inite's role
inite defined the traceability data model and naming standards, aligned teams on what "done" means from a traceability perspective, specified the integrations and governance, and delivered an MVP scope and rollout plan.
Customer quote

“Before, we lost time proving what a change was for and where the evidence lived. With inite's approach and the traceability graph, we can answer those questions fast, align across disciplines, and go into reviews with confidence.”

Head of R&D · Remote Patient Monitoring MedTech Company

Department Introduction · German biopharma client

Background
A contrast-media research department disrupted by frequent stakeholder changes and shifting business priorities: repeated introductions, misalignment on research scope, and time lost re-explaining who does what.
Solution
An Innovation Journey workshop to align on objectives and pinpoint bottlenecks, then a quick win: an online department introduction presenting the team's roles, goals, lab videos, FAQs, and key documents.
Results
Instant visibility for the research team. Stakeholder expectations managed. Redundant introductions for new stakeholders eliminated, and scope changes now clearly articulated together with their timeline impact.
inite's role
inite delivered the introduction end to end: interviewed scientists and lab heads, consolidated the feedback into the online introduction, ensured deployment and relevancy, and managed timelines and communication with minimum disruption.
Customer quote

“inite helped us define our goals and identify areas for improvement in our processes to increase efficiency and meet our objectives. The project is still ongoing, but we are already seeing the value of the work performed by inite.”

Head of Contrast Media Research · Global Pharma Company

Data Model & Ontology · German biopharma client

Background
A contrast-media research department aiming to accelerate the transition from early research to early development, but with data scattered across spreadsheets, formats, and workflows, and no shared view of what exists, where it sits, or how it flows.
Solution
A solution-agnostic initiative to define a contrast-media-focused data model and agreed ontology: a shared end-to-end view of what data exists, how it flows across research units, and how it should be structured to be FAIR, consistent, and reusable.
Results
Shared clarity on what data exists, where it sits, and how it flows across the research workflow. Aligned definitions and KPI readiness for more reliable decisions. Clearer ownership, gaps surfaced early, and a scalable, future-proof blueprint for AI- and ML-ready data capture.
inite's role
inite led the as-is analysis of spreadsheets, formats, and workflows, identified gaps and inconsistencies, designed the to-be conceptual data model and end-to-end data-flow framework, and facilitated alignment workshops on key entities, definitions, and ontology.
Customer quote

“The data model and ontology gave us a shared language and a clear end-to-end view of how information flows across our research. It created a solid, FAIR-ready foundation we can now use to standardise capture, improve consistency, and enable future digitalisation and advanced analytics.”

Head of Contrast Media Research · Global Pharma Company

AI & Automation Enablement Factory · German biopharma client

Background
Plenty of digitalisation and AI ideas in the research team, but no consistent way to turn them into delivered solutions. Data was hard to search, not interoperable, and rarely reused.
Solution
An AI & Automation Enablement Factory: a continuous stream of high-impact digitalisation, automation, and AI use cases, value-based and run in 90-day cycles. The client keeps final prioritisation authority; each delivered use case becomes a reusable building block that shortens the research cycle.
Results
A continuous pipeline of use cases improving scientists' workflows. Two enabling layers established: Data Infrastructure for access and search, Data Intelligence for AI-based structuring and insights. Higher internal alignment and adoption through a transparent, value-based delivery rhythm.
inite's role
Per use case, inite provided the Product Owner, Program Manager, and AI & Automation Expert. Facilitated discovery and prioritisation, translated needs into requirements, managed delivery and risk, and tracked measurable value, with a quarterly steering committee deciding each next 90 days.
Customer quote

“Before the factory, we had many ideas but no consistent way to turn them into delivered solutions. The 90 day cycles gave us a clear rhythm, kept prioritisation in our hands, and produced tangible improvements in how our scientists find, reuse, and work with data.”

Head of Contrast Media Research · Global Pharma Company

05 · the lenses

Three lenses, one engagement.

We map your bottleneck onto whichever of these gets it shipped fastest.

Scientific Advisory

  • Smart Lab Design
  • Predictive Market Intelligence
  • AI-Assisted Implementation

Process Improvement

  • Intelligent Business Analysis
  • Automated Decision Support
  • AI-Driven Transformation
  • Change Management

Technology

  • AI-Powered Sourcing
  • Smart R&D Automation
  • Intelligent Operations

why us

What every client comes to us for, whatever their field.

  1. AI that delivers on your goals.

    No slide decks, no chatbots. Working tools in your team’s hands, not another strategy workshop.

  2. Buy, build, or skip.

    Straight advice on what is worth building, buying, or leaving, carried from pilot through to production.

  3. Startup speed. Corporate delivery.

    Startup pace with the rigour your regulated world needs. Tailored rollout, at a speed that fits you.

06 · why inite

Basel-native.

Rooted in Basel. Roche and Novartis are within 15 minutes.

Boutique, senior practitioners only.

You work directly with the founders and named subject-matter experts. No juniors on your project.

Swiss & EU data handling.

Work product stays in Swiss/EU jurisdictions. Scheduling and communications use Microsoft 365 under standard contractual clauses.

Outcome-anchored, not slideware.

Every engagement ends in a working artifact: a PoC, a costed roadmap, a running automation.

Professional. Disruptive. Demanding.

Three words we answer to.

07 · the people

You'll work directly with this team.

Portrait of Andrin Linggi
Andrin Linggi
CFO & Co-founder

Builds reliable, future-proof processes. M.A. Business Innovation (HSG). Prince II, COBIT, SAFe, Scrum PSM I. Background across R&D, procurement, compliance, diagnostics, and commercials.

LinkedIn →
Portrait of David Junker
David Junker
CEO & Co-founder

Bridges C-level strategy with bench-level science. Transitioned from finance into life sciences; 10+ years across clinical studies, regulatory data, manufacturing, and biotech AI. M.A. International Management; computer-science background.

LinkedIn →
Portrait of Stefan Foser, PhD, MBA
Stefan Foser, PhD, MBA
Pharma & MedTech Innovation Leader

Pharma and MedTech innovation leadership across research, diagnostics and product development. Eager to build solutions that accelerate the scientific ecosystem.

LinkedIn →
Portrait of Alice Mahieu
Alice Mahieu
MedTech & Digital Health

MedTech, biotech and healthcare digital transformation; business analysis from user need to validated rollout. Analytical thinker, people connector and grounded achiever.

LinkedIn →
Portrait of Alex Dufner
Alex Dufner
CTO

AI and technology leader; our lead engineer. Architects and builds the tools and platforms our clients run on.

LinkedIn →

inite = ig-nite + unite.

The spark that kindles R&D potential; the backbone that unites science, business, and technology.

08 · resources

To forward internally.

09 · talk

Tell us the bottleneck.
We'll tell you the path.

Primary

Book a free R&D Strategy Call

30 min with a founder. No deck, no pitch.

Secondary

Or email us

For deeper asks (procurement onboarding, NDAs, custom scopes), email works best.

info@inite.com →

Book a call

Pick the conversation that fits where you are. Both are free 30-minute calls. No deck, no pitch.